About Me
Bobby Liaw, M.D. specializes in the care and management of patient's with genitourinary and sarcoma cancers. He serves as the Clinical Director of Genitourinary Oncology for the Mount Sinai Health System, as well as the Medical Director for the Blavatnik Family Chelsea Medical Center at Mount Sinai.
He received his undergraduate degree at Cornell University, medical education at SUNY Downstate College of Medicine, graduated internal medicine residency from Beth Israel Deaconess Medical Center and completed his hematology/oncology fellowship training at Mount Sinai.
In addition to providing multidisciplinary care in the fields of genitourinary and sarcoma cancers, he is actively involved in clinical research. His main academic interests are in the translational and clinical investigation of genitourinary malignancies, with particular interests in developing new biomarkers and treatment strategies for metastatic castration-resistant prostate cancer.
A close personal interest of his is to help bridge cultural gaps in order to improve quality and access to healthcare to the Asian American community.
Language
Chinese (Mandarin), EnglishPosition
ASSISTANT PROFESSOR | Medicine, Hematology and Medical OncologyHospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Morningside and Mount Sinai West
About Me
Bobby Liaw, M.D. specializes in the care and management of patient's with genitourinary and sarcoma cancers. He serves as the Clinical Director of Genitourinary Oncology for the Mount Sinai Health System, as well as the Medical Director for the Blavatnik Family Chelsea Medical Center at Mount Sinai.
He received his undergraduate degree at Cornell University, medical education at SUNY Downstate College of Medicine, graduated internal medicine residency from Beth Israel Deaconess Medical Center and completed his hematology/oncology fellowship training at Mount Sinai.
In addition to providing multidisciplinary care in the fields of genitourinary and sarcoma cancers, he is actively involved in clinical research. His main academic interests are in the translational and clinical investigation of genitourinary malignancies, with particular interests in developing new biomarkers and treatment strategies for metastatic castration-resistant prostate cancer.
A close personal interest of his is to help bridge cultural gaps in order to improve quality and access to healthcare to the Asian American community.
Language
Chinese (Mandarin), EnglishPosition
ASSISTANT PROFESSOR | Medicine, Hematology and Medical OncologyHospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Morningside and Mount Sinai West
About Me
Bobby Liaw, M.D. specializes in the care and management of patient's with genitourinary and sarcoma cancers. He serves as the Clinical Director of Genitourinary Oncology for the Mount Sinai Health System, as well as the Medical Director for the Blavatnik Family Chelsea Medical Center at Mount Sinai.
He received his undergraduate degree at Cornell University, medical education at SUNY Downstate College of Medicine, graduated internal medicine residency from Beth Israel Deaconess Medical Center and completed his hematology/oncology fellowship training at Mount Sinai.
In addition to providing multidisciplinary care in the fields of genitourinary and sarcoma cancers, he is actively involved in clinical research. His main academic interests are in the translational and clinical investigation of genitourinary malignancies, with particular interests in developing new biomarkers and treatment strategies for metastatic castration-resistant prostate cancer.
A close personal interest of his is to help bridge cultural gaps in order to improve quality and access to healthcare to the Asian American community.
Language
Chinese (Mandarin), EnglishPosition
ASSISTANT PROFESSOR | Medicine, Hematology and Medical OncologyHospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Morningside and Mount Sinai West
Clinical Focus
- Adrenal Gland Tumors
- Bladder Cancer
- Genitourinary Malignancies
- Kidney Cancer
- Prostate Cancer
- Renal Cancer
- Sarcomas
- Sarcomas, Soft-Tissue
- Testicular Tumors
- Adrenal Gland Tumors
- Bladder Cancer
- Genitourinary Malignancies
- Kidney Cancer
- Prostate Cancer
- Renal Cancer
- Sarcomas
- Sarcomas, Soft-Tissue
- Testicular Tumors
Education
MD, SUNY Downstate Medical Center
Internship , Internal Medicine
Beth Israel Deaconess Medical Center- Harvard Medical School
Residency , Internal Medicine
Beth Israel Deaconess Medical Center- Harvard Medical School
Residency , Hematology
The Mount Sinai Hospital
Fellowship, Hematology
The Mount Sinai Hospital
Research
Anti-Tumor Therapy, Cancer, Drug Resistance, Prostate
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Liaw did not report having any of the following types of financial relationships with industry during 2021 and/or 2022: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Doctors
Accepting New Patients
